Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 9, 1998, Pages 3163-3168

  Laureti, Stefano ^a   Aubourg, Patrick ^b   Calcinaro, Filippo ^a   Rocchiccioli, Francis ^b   Casucci, Giovanni ^a   Angeletti, Gabriella ^a   Brunetti, Paolo ^a   Lernmark, Åke ^c   Santeusanio, Fausto ^a   Falorni, Alberto ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b INSERM   (France)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; PANCREAS ISLET CELL ANTIBODY; STEROID 21 MONOOXYGENASE; THYROID PEROXIDASE;

ADOLESCENT; ADRENAL INSUFFICIENCY; ADRENOLEUKODYSTROPHY; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; DISEASE DURATION; FEMALE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADRENAL CORTEX; ADRENAL INSUFFICIENCY; ADRENOLEUKODYSTROPHY; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; FATTY ACIDS; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; IODIDE PEROXIDASE; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; STEROID 21-HYDROXYLASE; TUBERCULOSIS; X CHROMOSOME;

EID: 7844227670     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.9.3163     Document Type: Article

References (42)

1. Mason AS, Meade TW, Lee JAH, Morris JN. 1968 Epidemiological and clinical picture of Addison's disease. Lancet. II:744-747.
2. Nerup J. 1974 Addison's disease. Clinical studies. A report of 108 cases. Acta Endocrinol (Copenh). 76:127-141.
3. Zelissen PMJ, Bast EJEG, Croughs RJM. 1995 Associated autoimmunity in Addison's disease. J Autoimmun. 8:121-130.
4. Oelkers W. 1996 Adrenal insufficiency. N Engl J Med. 335:1206-1212.
5. Partanen J, Peterson P, Westman P, Aranko P, Krohn K. 1994 Major histocompatibility complex class II and class III in Addison's disease. MHC alleles do not predict autoantibody specificity and 21-hydroxylase gene polymorphism has no independent role in disease susceptibility. Hum Immunol. 41:135-140.
6. Bigazzi PE. 1985 Autoimmunity of the adrenals. In: Volpé R, ed. Autoimmunity and endocrine disease. New York: Marcel Dekker; 345-373.
7. Winqvist O, Söderbergh A, Kämpe O. 1996 The autoimmune basis of adrenocortical destruction in Addison's disease. Mol Med Today. 2:282-289.
8. Irvine WJ, Barnes EW. 1975 Addison's disease, ovarian failure, and hypoparathyroidism. Clin Endocrinol Metab. 4:379-434.
9. Sotsiou F, Bottazzo GF, Doniach D. 1980 Immunofluorescence studies on autoantibodies to steroid-producing cells and to germline cells in endocrine diseases and infertility. Clin Exp Immunol. 39:97-111.
10. Chen S, Sawicka J, Betterle C, et al. 1996 Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J Clin Endocrinol Metab. 81:1871-1876.
11. Winqvist O, Karlsson FA, Kämpe O. 1992 21-hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet. 339:1559-1562.
12. Bednarek J, Furmaniak J, Wedlok N S, et al. 1992 Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease. FEBS Lett. 309:51-55.
13. Falorni A, Nikoshkov A, Laureti S, et al. 1995 High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab. 80:2752-2755.
14. Falorni A, Laureti S, Nikoshkov A, et al. 1997 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Clin Exp Immunol. 107:341-346.
15. Krohn K, Uibo R, Aavik E, Peterson P, Svailahti K. 1992 Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17α-hydroxylase. Lancet. 339:770-773.
16. Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kämpe O. 1993 Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyglandular syndrome type I and Addison's disease. J Clin Invest. 92:2377-2385.
17. Söderbergh A, Winqvist O, Norheim I, et al. 1996 Adrenal autoantibodies and organ-specific autoimmonity in patients with Addison's disease. Clin Endocrinol (Oxf). 45:453-460.
18. Shah B, Taylor HC, Pillay I, Chung-Park M, Dobrinich R. 1986 Adrenal insufficiency due to cryptococcosis. JAMA. 256:3247-3249.
19. Werbel SS, Ober KP. 1993 Acute adrenal insufficieny. Endocrinol Metab Clin North Am. 22:303-328.
20. Sheeler LR, Myers JH, Eversman JJ, Taylor HC. 1983 Adrenal insufficiency secondary to carcinoma metastatic to the adrenal gland. Cancer. 52:1312-1316.
21. Lin D, Sugawara T, Strauss III JF, et al. 1995 Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science. 267:1828-1831.
22. Muscatelli F, Strom TM, Walker AP, et al. 1994 Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature. 372:672-676.
23. Weber A, Wienker TF, Jung M, et al. 1996 Linkage of the gene for the triple A syndrome to chromosome 12q13 near the type II keratin gene cluster. Hum Mol Genet. 5:2061-2066.
24. Moser H, Smith K, Moser A. 1995 X-linked adrenoleukodystrophy. In: Scriver CR, Beaudet AL, Sly WL, Valle D, eds. The metabolic bases of inherited disease, 7th ed. New-York: McGraw-Hill; 2325-2349.
25. Aubourg P. 1996 X-linked adrenoleukodystrophy. In: Vinken PJ, Bruyn, GW, Moser HW, eds. Handbook of clinical neurology: Neurodystrophies and neurolipidoses. Amsterdam: Elsevier; 447-483.
26. Sadeghi-Nejad A, Senior B. 1990 Adrenomyeloneuropathy presenting as Addison's disease in childhood. N Engl J Med. 322:13-16.
27. Korenke GC, Roth C, Krasemann E, Hüfner M, Hunneman DH, Hanefeld F. 1997 Variability of endocrinological dysfunction in 55 patients with X-linked adrenoleukodystrophy: clinical, laboratory and genetic findings. Eur J Endocrinol. 137:40-47.
28. Aubourg P, Chaussain JL. 1991 Adrenoleukodystrophy presenting as Addison's disease in children and adults. Trends Endocrinol Metab. 2:49-52.
29. Blizzard RM, Kyle M. 1963 Studies of the adrenal antigens and antibodies in Addison's disease. J Clin Invest. 42:1653-1660.
30. Betterle C, Scalici C, Presotto F, et al. 1988 The natural history of adrenal function in antoimmune patients with adrenal autoantibodies. J Endocrinol. 117:467-475.
31. Bonifacio E, Bingley PJ, Shattock M, et al. 1990 Quantification of islet cell antibodies and prediction of insulin dependent diabetes. Lancet. 335:147-149.
32. 3H recombinant human ligands. J Immunol Methods. 186:89-99.
33. Gianani R, Rabin DU, Verge CF, et al. 1995 ICA512 antoantibody radioassay. Diabetes. 44:1340-1344.
34. Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, et al. 1993 A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy. N Engl J Med. 329:745-752.
35. Laureti S, Casucci G, Santeusanio F, Angeletti G, Aubourg P, Brunetti P. 1996 X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients. J Clin Endocrinol Metab. 81:470-474.
36. Jorge P, Quelhas D, Oliveira P, Pinto R, Nogueira A. 1994 X-linked adrenoleukodystrophy in patients with idiopathic Addison disease. Eur J Pediatr. 153:594-597.
37. Papadopoulos KI, Hallengren B. 1990 Polyglandular autoimmune syndrome Type II in patients with idiopathic Addison's disease. Acta Endocrinol (Copenh). 122:472-478.
38. Wuepper KD, Wegienka LC, Fudemberg HH. 1969 Immunological aspects of adrenocortical insufficiency. Am J Med. 46:206-216.
39. Fanen P, Guidoux S, Sarde CO, Mandel JL, Goossens M, Aubourg P. 1994 Identification of mutations in the putative ATP-binding domain of the adrenoleukodystrophy gene. J Clin Invest. 94:516-520.
40. Feigenbaum V, Lombard-Platet G, Guidoux S, Sarde CO, Mandel JL, Aubourg P. 1996 Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy. Am J Hum Genet. 58:1135-1144.
41. Aubourg P, Blanche S, Jambaqué I, et al. 1990 Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med. 322:1860-1866.
42. Krivit W, Lockman LA, Watkins PA, Hirsch J, Shapiro EG. 1995 The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. J Inherited Metab Dis. 18:398-412.